News &
Media
-
‘Autism Epidemic Runs Rampant,’ New Data Shows 1 in 31 Children Afflicted
View More: ‘Autism Epidemic Runs Rampant,’ New Data Shows 1 in 31 Children Afflicted -
Neurotech inks European development deal for cannabinoid therapies
View More: Neurotech inks European development deal for cannabinoid therapies -
Rare opportunities – ASX health stocks tackling unmet medical needs
View More: Rare opportunities – ASX health stocks tackling unmet medical needs -
Neurotech International Achieves Key Milestone For Cannabis-based Rett Syndrome Drug
View More: Neurotech International Achieves Key Milestone For Cannabis-based Rett Syndrome Drug -
US FDA grants coveted Orphan Drug Designation for NTI’s Rett Syndrome Treatment
View More: US FDA grants coveted Orphan Drug Designation for NTI’s Rett Syndrome Treatment -
Break it Down: Neurotech’s human adult study tick of approval for cannabinoid drug
View More: Break it Down: Neurotech’s human adult study tick of approval for cannabinoid drug -
Dr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025
View More: Dr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025 -
Groundbreaking trial for those with Rett Syndrome | 7NEWS
View More: Groundbreaking trial for those with Rett Syndrome | 7NEWS -
Neurotech’s cannabinoid drug reverses immune dysregulation in PANDAS/PANS kids
View More: Neurotech’s cannabinoid drug reverses immune dysregulation in PANDAS/PANS kids